Efficacy of Colchicine in the treatment of COVID-19

Phase 3

Recruiting

• Conditions: Covid 19.; COVID-19, virus identified; U07.2

• Registration Number: IRCT20211017052786N1
• Lead Sponsor: Ghoum University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 February 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

People who are definitely hospitalized for Covid-19 diagnosis and are under mechanical ventilation
Minimum age age of 30

Exclusion Criteria

Patients over age of 60
The patients who are pregnant or have an infant child
Patients with liver enzyme problems
Patients who are intubated in less than 24 hours

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
CRP level of the patient's blood. Timepoint: The first and fifth day of study. Method of measurement: Patient blood test.;Patient's blood lymphocyte count. Timepoint: The first and fifth days of study. Method of measurement: Patient blood test.